Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Nand

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 1, 1995
Shoulder dystocia. Report of 2 cases and review of the literatureS L Nand
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 1995
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changesS L Nand, M A Webster, B G Wren
Obstetrics and Gynecology|May 8, 1998
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study GroupS L Nand, M A Webster, R Baber, et al.
Climacteric : the Journal of the International Menopause Society|March 27, 2002
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study GroupS L Nand, M A Webster, R Baber, et al.
Obstetrics and Gynecology|June 11, 1999
Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Ogen/Provera Study GroupS L Nand, B G Wren, B A Gross, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 1, 1995
Shoulder dystocia. Report of 2 cases and review of the literatureS L Nand
The Australian & New Zealand Journal of Obstetrics & Gynaecology|February 1, 1995
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changesS L Nand, M A Webster, B G Wren
Obstetrics and Gynecology|May 8, 1998
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study GroupS L Nand, M A Webster, R Baber, et al.
Climacteric : the Journal of the International Menopause Society|March 27, 2002
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study GroupS L Nand, M A Webster, R Baber, et al.
Obstetrics and Gynecology|June 11, 1999
Bone density effects of continuous estrone sulfate and varying doses of medroxyprogesterone acetate. Ogen/Provera Study GroupS L Nand, B G Wren, B A Gross, et al.
Pageof 1